Acute Hepatic Porphyria and Liver Cancer
Author Information
Author(s): R. Kauppinen, P. Mustajoki
Primary Institution: University of Helsinki
Hypothesis
What is the incidence and relative risk of hepatocellular carcinoma (HCC) among adults with acute hepatic porphyria in Finland?
Conclusion
The study found a significantly increased risk of hepatocellular carcinoma among patients with acute hepatic porphyria.
Supporting Evidence
- The incidence of HCC among porphyric patients was found to be 151 per 100,000.
- Among deceased patients, 9% died from hepatocellular carcinoma.
- The relative risk of HCC in patients with acute intermittent porphyria was calculated to be 60.98.
Takeaway
People with a rare disease called acute hepatic porphyria have a much higher chance of getting liver cancer compared to others.
Methodology
The study analyzed case histories of 163 living and 82 deceased Finnish patients with acute hepatic porphyria, examining causes of death and calculating the relative risk of HCC.
Potential Biases
Patients with porphyria are closely monitored, which may lead to more frequent detection of liver tumors compared to the general population.
Limitations
The study may underestimate the risk of HCC due to potential misdiagnosis in earlier years and the exclusion of some patients.
Participant Demographics
The study included 163 living patients (62 men, 101 women) with a mean age of 45 years and 82 deceased patients (42 men, 40 women) with a mean age at death of 57 years.
Statistical Information
P-Value
60.98
Confidence Interval
17.75-145.25
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website